| 764578 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
571 IL-2 combination with ImmTAC overcomes CD163+ TAM-like M2 macrophage inhibition of ImmTAC-mediated T cell killing of tumor cells |
2021-11-01 |
10.1136/jitc-2021-sitc2021.571 |
Khanolkar Rahul, Naidoo Revashnee, Güç Esra, Leach Emma, Stanhope Sarah, Gascoyne Duncan, Collins Laura, Ranade Koustubh, Benlahrech Adel |
| 764577 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
441 Population pharmacokinetics of an anti-PD-1 antibody, Penpulimab in patients with advanced malignancies |
2021-11-01 |
10.1136/jitc-2021-sitc2021.441 |
Chen Benchao, Jin Xiaoping, Dong Yongcheng, Wang Max, Xia Dennis, Xia Michelle, Li Baiyong |
| 764576 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
80 Cancer testis antigen burden: A novel predictive biomarker for immunotherapy in solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.080 |
Pabla Sarabjot, Seager RJ, Lee Yong Hee, Roey Erik Van, Gao Shuang, Giamo Vincent, Burgher Blake, DePietro Paul, Nesline Mary, Glenn Sean, Zhang Shengle, Conroy Jeffrey |
| 764575 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
79 Extensively validated HLA LOH algorithm demonstrates an association between HLA LOH and genomic instability |
2021-11-01 |
10.1136/jitc-2021-sitc2021.079 |
Pyke Rachel, Dea Steven, Mellacheruvu Dattatreya, Abbott Charles, Zhang Simo, McDaniel Lee, Levy Eric, Bartha Gabor, West John, Snyder Michael, Chen Richard, Boyle Sean |
| 764574 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
78 Novel RNA-seq platform improve patient outcome in clinical oncology and enable implementation of AI in the clinic |
2021-11-01 |
10.1136/jitc-2021-sitc2021.078 |
Nguyen Vy, Pedersen Gitte, Pedersen Morten |
| 764573 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
77 Prevalence of secondary immunotherapeutic targets in the absence of established immune biomarkers in solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.077 |
DePietro Paul, Nesline Mary, Lee Yong Hee, Seager RJ, Roey Erik Van, Gao Shuang, Giamo Vincent, Burgher Blake, Glenn Sean, Zhang Shengle, Klein Roger, Pabla Sarabjot, Conroy Jeffrey |
| 764572 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
71 Tumors with higher heterogeneity were associated with superior survival outcome amongst stage I lung cancer patients with low tumor mutational burden (TMB) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.071 |
Fridland Stanislav, Chae Young Kwang |
| 764571 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
69 Immunophenotyping of TCR and BCR clonotypes |
2021-11-01 |
10.1136/jitc-2021-sitc2021.069 |
Chenchik Alex, Makhanov Michael, Darst Russell, Liu Tianbing, Kobzik Lester |
| 764570 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
66 Prognostic and predictive value of pre-treatment T-cell receptors (TCR) repertoire in non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.066 |
Abed Afaf, Gray Elin, Millward Michael |
| 764569 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
65 Identification of frequently presented non-mutated tumor-specific immunogens for the development of both off-the-shelf and personalized vaccines without need for tumor biopsy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.065 |
Lorincz Orsolya, Molnar Levente, Csiszovszki Zsolt, Somogyi Eszter, Toth Jozsef, Pantya Katalin, Pales Peter, Toke Eniko |
